Abstract: The present invention describes the application of sirolimus and analogs of sirolimus to treat wound healing and reduce scar tissue formation. Also contemplated are non-sirolimus compounds believed to interact with the mTOR protein that have similar effects. Specifically, various medium are contemplated to create, for example, microparticles, foams, gels, sprays and bioadhesives that may be administered during surgical procedures involving either open or closed surgical site. Coating medical devices for long-term implantation is contemplated as one method of use of the above compositions.

Abstract: The present invention provides real time call control within a telecommunications network, using a call selection processor separate from the switches carrying the call, which responds to incoming calls and uses information carried in the associated signaling messages to determine what application processor, if any, should be involved on the call. One embodiment of the present invention includes a call selection processor called a signaling director", or "SD" for short, for recognizing certain signaling messages, typically SS7 initial address messages (IAM's), as the messages flow through the signaling network. Alternatively, particular signaling messages may be recognized in a signaling message processing element within the signaling network, such as the signal transfer point (STP) associated with the switch that receives the telephone calls, and a copy of those particular messages forwarded to the SD.

Abstract: A telephone services functionality is disposed in a telecommunications network to ensure that a telephone call is processed in accordance with the telephone services respectively subscribed to by the calling and called parties. In addition, the functionality retains control over the call so that it may respond to service requests entered by either the calling or called party at any point following establishment of the call connection.